Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03753542
Recruitment Status : Unknown
Verified February 2019 by Nomi Waqas Gul, Dow University of Health Sciences.
Recruitment status was:  Active, not recruiting
First Posted : November 27, 2018
Last Update Posted : February 11, 2019
Sponsor:
Collaborator:
Indus Hospital and Health Network
Information provided by (Responsible Party):
Nomi Waqas Gul, Dow University of Health Sciences

Brief Summary:

ABSTRACT

Background:

Today, a wide range of pediatric cancers is treated by chemotherapy. More than 21 side effects of chemotherapy have been identified. Among those nausea; vomiting, infection and anemia are most common. The adverse effects are normally managed by the parents at home. Ineffective coping and lack of knowledge about chemotherapy side effect management leads parents stress. Contemporary research evidence that Nurse-led education, booklet providence and follow up about chemotherapy and side effect management, help to decrease parents anxiety and depression.

Objectives:

To measure the effect of nurse-led multimedia education, booklet providence and telephonic follow up about chemotherapy and side effects management on parents anxiety and depression of children receiving chemotherapy for the first time.

Methodology:

A randomized control trial will be conducted in the department of chemotherapy at Indus Children Cancer Hospital Karachi from March 2018 to August 2018 on parents of children below 18 years of age undergoing chemotherapy for the first time. Total 100 parents will be randomly divided into Intervention group (n=50) and Control Group (n=50). The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management. The Control group will receive routine care. Parent's anxiety and depression will be identified by using DASS-21 and generalized estimating estimation will be used to analyzed the data.

Keywords:

Nurse-led, Multimedia education, Booklet, telephonic follow-up, chemotherapy, side effects, parents, anxiety, depression, children, cancer


Condition or disease Intervention/treatment Phase
Chemotherapy Effect Other: Multimedia education, booklet Providence and tele-nursing follow-up Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The sample size calculated was 30 samples per group. After adjusting error in non-response of data collection 50 samples will be drown from each group. Total 100 caregivers along with their children will be selected.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy
Actual Study Start Date : September 6, 2018
Actual Primary Completion Date : December 30, 2018
Estimated Study Completion Date : March 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: Intervention
The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management
Other: Multimedia education, booklet Providence and tele-nursing follow-up
Multimedia education, booklet and weekly tele-nursing follow-up is about chemotherapy and side effects management

No Intervention: Control
The Control group will receive routine care



Primary Outcome Measures :
  1. Depression, Anxiety and Stress Scale - 21 (DASS-21) [ Time Frame: up to 4 weeks ]
    Depression (D) and anxiety (A) and stress(S) will be outcome variable. They will be identified by using DASS-21 Scale. The use of DASS-21 Scale is evident in Pakistan . There are 21 questions in this scale equally divided in to three parts having seven questions for Depression, Anxiety and stress respectively. Each question have four level of measurement 0,1, 2 and 3, represent past week experiences. 0 means not applicable to person, 1 means applicable to some degree or sometime, 2 means applicable to considerable degree or good part of time, 3 means applicable to person very much or most of the time. Each question is separate for Stress(s), Anxiety (a) and Depression (d).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Parents along with their children younger than 18 years of age
  2. Parents along with their children newly diagnosed with cancer in last three weeks
  3. Parents along with their children schedule to receive first time chemotherapy in the outpatient department

Exclusion Criteria:

  1. Parents along with their children refused to participate
  2. Parents along with their children already receiving interventions like multimedia education, booklet providence and telephonic follow up for chemotherapy and side effect management
  3. Parents taking medicine for their anxiety and depression. (e.g. Anxiolytics/ Antidepressant)
  4. Parents showing uneasiness and discomfort during educational session.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03753542


Locations
Layout table for location information
Pakistan
Indus Children Cancer Hospital Karachi
Karachi, Sindh, Pakistan
Sponsors and Collaborators
Nomi Waqas Gul
Indus Hospital and Health Network
Investigators
Layout table for investigator information
Study Chair: Dr. Mehwish HUSSAIN, PhD (Statistics) Senior Lecturer, DUHS, Karachi
Study Chair: Dr. SHAMVIL ASHRAF, MBBS, DCH, MCPS, FCPS, MRCP Indus Hospital Karachi
Study Chair: Mr. Hakim Shah, MSN Associate Professor Institute of Nursing Dow University of Health Sciences Karachi
Publications:
CCHK. Children cancer Hospital karachi. 2017 [cited 2017; Available from: http://ccfpakistan.org/.
Mansoor, S. and S. Jehangir, Anxiety, depression in patient receving chemotherapy for solid tumors. Pak Armed Forces Med. J, 2015. 65(1): p. 89-93.
Pouresmail, Z., S. Sharafi, and M. Razi, The Role of Evidence Based Nursing in Prevention of Gastrointestinal Side Effects of Chemotherapy in Children with Cancer. International Journal of Pediatrics, 2014. 2(2.1): p. 48-48
Mohammed, H.A., Impact of proposed nursing rehabilitation program on self management of selected side effects of chemotherapy for elderly patints with gastrointestinal cancer. CU Theses, 2012.
Lerdkiattikorn, P., et al., Quality of life among stage III colon cancer patients receiving oral and intravenous chemotherapy regimens in Thailand. Mahidol University Journal of Pharmaceutical Sciences, 2012. 39: p. 41-3.
Kutlu, R., et al., Kanserli hastalarda depresyon ve yaşam kalitesini etkileyen faktörler. Selçuk Üniv Tıp Derg, 2011. 27(3): p. 149-153
Network, N.C.C. Distress management. In NCCN Clinical Practice Guidelines in Oncology. . 2017; Available from: http://www.nccn.org.
Yasin, Y.M. and A. Al-Hamad, ANXIETY AND DEPRESSION AS KEY DETERMINANTS OF CANCER RELATED FATIGUE AMONG PATIENTS RECEIVING CHEMOTHERAPY. European Scientific Journal, ESJ, 2015. 11(33)
Sarafraz Nasab, M. and M. Mojtabaie, P116: Reminiscence Therapy Efficacy in Reducing Symptoms of Anxiety in Elderly Nursing Home Residents in Tehran. The Neuroscience Journal of Shefaye Khatam, 2014. 2(3): p. 140-140.
Zakerimoghadam, M., S. Ghiasvandian, and P. Salahshoor, The effect of supportive nursing program on depression, anxiety and stress of family members of patients during coronary artery bypass graft (CABG) surgery. Iranian Journal of Cardiovascular Nursing, 2014. 3(1): p. 50-58

Layout table for additonal information
Responsible Party: Nomi Waqas Gul, Principal Investigator, Dow University of Health Sciences
ClinicalTrials.gov Identifier: NCT03753542    
Other Study ID Numbers: Enr # 12/2015/912
First Posted: November 27, 2018    Key Record Dates
Last Update Posted: February 11, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No plan

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Nomi Waqas Gul, Dow University of Health Sciences:
chemotherapy, side effects, parents, anxiety, depression
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Behavioral Symptoms